510(k) device
NObreath®
Bedfont Scientific, Ltd. · System, Test, Breath Nitric Oxide (MXA, Class II) · First FDA decision Dec 17, 2021, newest Dec 17, 2021Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "NObreath"
MAUDE reports
0
Brand "NObreath", since 2015
PubMed studies
19
Mentioning "NObreath"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NObreath®
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- NObreath®510(k)
K203695 · Decided Dec 17, 2021 · 364 days after receipt
Device type: System, Test, Breath Nitric Oxide (MXA) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NObreath", any status and sponsor, newest update first.
No registered device study names "NObreath".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NObreath", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MXA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NObreath"[tiab]. The summary above synthesizes these.
- Comparison of fractional exhaled nitric oxide levels measured by different analyzers produced by different manufacturers.
Saito J, Kikuchi M, Fukuhara A, et al. · J Asthma · 2020Comparative Study, Observational Study
- Fractional exhaled nitric oxide: comparison between portable devices and correlation with sputum eosinophils.
Yune S, Lee JY, Choi DC, et al. · Allergy Asthma Immunol Res · 2015
- Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children.
Alzayadneh EM, Al Bdour SA, Elayeh ER, et al. · J Asthma Allergy · 2023
- Assessment of exhaled nitric oxide by a new hand-held device.
Antus B, Horvath I, Barta I · Respir Med · 2010Research Support, Non-U.S. Gov't
- Measurement of fractional exhaled nitric oxide by a new portable device: comparison with the standard technique.
Pisi R, Aiello M, Tzani P, et al. · J Asthma · 2010Comparative Study
- Is a 12-h Nitrox dive hazardous for pulmonary function?
Castagna O, Bergmann C, Blatteau JE · Eur J Appl Physiol · 2019
- Comparative repeatability of two handheld fractional exhaled nitric oxide monitors.
Kapande KM, McConaghy LA, Douglas I, et al. · Pediatr Pulmonol · 2012Comparative Study, Evaluation Study
- Performance of two portable exhaled nitric oxide fraction devices compared to a "gold standard" chemiluminescence device.
Thanikkel L, Vogt A, Micic SJ, et al. · ERJ Open Res · 2025
- Measurement of Fractional Exhaled Nitric Oxide in Adults: Comparison of Two Different Analyzers (NIOX VERO and NObreath).
Kang SY, Lee SM, Lee SP · Tuberc Respir Dis (Seoul) · 2021
- [DIFFERENCES IN FRACTION OF EXHALED NITRIC OXIDE VALUES MEASURED BY TWO HAND-HELDED ANALYZERS (NObreath® AND NIOX Vero®)].
Tsuburai T, Kamide Y, Nakamura Y, et al. · Arerugi · 2017
- Measurement of Exhaled Nitric Oxide in Children: A Comparison Between NObreath® and NIOX VERO® Analyzers.
Inoue Y, Sato S, Manabe T, et al. · Allergy Asthma Immunol Res · 2018
- Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis.
Takeno S, Taruya T, Ueda T, et al. · Auris Nasus Larynx · 2013Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MXA.
- NIOX VERO Airway Inflammation MonitorAerocrine AB · 510(k) 2015
- Niox Mino Model 09-1000Aerocrine AB · 510(k) 2010
- Fenom Flo FeNO Monitoring SystemMgc Diagnostics Corporation · 510(k) 2025
- Vivatmo pro-SBosch Healthcare Solutions GmbH · 510(k) 2025
- Vivatmo proBosch Healthcare Solutions GmbH · 510(k) 2024
- Fenom ProCaire Diagnostics, Inc. · 510(k) 2023
- Fenom Pro Nitric Oxide TestSpirosure, Inc. · 510(k) 2019
- Niox VeroCircassia AB · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.